Cybrdi Inc (CYDI) financial statements (2023 and earlier)
Company profile
Business Address |
401 ROSEMONT AVENUE FREDERICK, MD 21701 |
State of Incorp. | CA |
Fiscal Year End | December 31 |
SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 68 | 52 | 887 | 204 | 965 | 967 | 980 | ||
Cash and cash equivalents | 68 | 52 | 887 | 204 | 965 | 967 | 980 | ||
Receivables | 89 | 81 | 50 | 6 | 8 | 16 | 16 | ||
Inventory, net of allowances, customer advances and progress billings | 803 | 809 | 798 | 849 | 846 | 832 | 825 | ||
Inventory | 803 | 809 | 798 | 849 | 846 | 832 | 825 | ||
Advances on inventory purchases | 5 | 4 | 0 | 5 | 5 | 4 | 4 | ||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 79 | ||
Other undisclosed current assets | 105 | 109 | 127 | 906 | 151 | 66 | |||
Total current assets: | 1,069 | 1,055 | 1,862 | 1,970 | 1,974 | 1,886 | 1,904 | ||
Noncurrent Assets | |||||||||
Property, plant and equipment | 1,091 | 1,084 | 1,091 | 1,145 | 1,183 | 1,184 | 1,190 | ||
Intangible assets, net (including goodwill) | 612 | 610 | 616 | 628 | 632 | 640 | 641 | ||
Intangible assets, net (excluding goodwill) | 612 | 610 | 616 | 628 | 632 | 640 | 641 | ||
Other undisclosed noncurrent assets | 7,868 | 7,785 | 6,536 | 6,610 | 7,046 | 6,976 | 6,940 | ||
Total noncurrent assets: | 9,572 | 9,478 | 8,243 | 8,383 | 8,862 | 8,800 | 8,771 | ||
TOTAL ASSETS: | 10,641 | 10,533 | 10,105 | 10,353 | 10,836 | 10,685 | 10,675 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 934 | 895 | 897 | 822 | 796 | 778 | 758 | ||
Accounts payable | 12 | 12 | 31 | 12 | 12 | 33 | 5 | ||
Accrued liabilities | 922 | 884 | 865 | 810 | 784 | 744 | 753 | ||
Debt | 1,466 | 1,451 | 1,448 | 1,309 | 163 | 1,699 | 1,691 | ||
Due to related parties | 2,446 | 2,352 | 3,016 | 2,963 | 3,919 | 2,236 | 2,114 | ||
Deferred revenue and credits | 132 | 131 | 131 | 126 | 126 | 125 | 124 | ||
Deferred tax liabilities | 11 | 10 | 10 | 11 | 11 | 10 | 10 | ||
Customer advances and deposits | 160 | 158 | ✕ | ✕ | ✕ | ✕ | |||
Other liabilities | 504 | 466 | 441 | 592 | 660 | 638 | 606 | ||
Other undisclosed current liabilities | 158 | 165 | 176 | 121 | 176 | ||||
Total current liabilities: | 5,654 | 5,464 | 6,100 | 5,988 | 5,851 | 5,606 | 5,479 | ||
Noncurrent Liabilities | |||||||||
Other undisclosed noncurrent liabilities | 1,623 | 1,606 | 370 | 376 | 872 | 864 | 859 | ||
Total noncurrent liabilities: | 1,623 | 1,606 | 370 | 376 | 872 | 864 | 859 | ||
Total liabilities: | 7,277 | 7,070 | 6,470 | 6,364 | 6,723 | 6,470 | 6,338 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 2,409 | 2,549 | 2,650 | 2,954 | 3,159 | 3,100 | 3,191 | ||
Common stock | 4,314 | 4,314 | 4,314 | 4,314 | 4,314 | 4,314 | 4,314 | ||
Additional paid in capital | 172 | 172 | 172 | 172 | 172 | 172 | 172 | ||
Accumulated other comprehensive income | 1,638 | 1,611 | 1,586 | 1,657 | 1,709 | 1,527 | 1,493 | ||
Accumulated deficit | (4,053) | (3,885) | (3,759) | (3,526) | (3,372) | (3,250) | (3,124) | ||
Other undisclosed stockholders' equity attributable to parent | 337 | 337 | 337 | 337 | 337 | 337 | 337 | ||
Stockholders' equity attributable to noncontrolling interest | 956 | 914 | 985 | 1,035 | 953 | 1,116 | 1,146 | ||
Total stockholders' equity: | 3,364 | 3,463 | 3,635 | 3,988 | 4,113 | 4,215 | 4,337 | ||
TOTAL LIABILITIES AND EQUITY: | 10,641 | 10,533 | 10,105 | 10,353 | 10,836 | 10,685 | 10,675 |
Income statement (P&L) ($ in thousands)
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 112 | 86 | 149 | 151 | 133 | 139 | 151 | |
Revenue, net | 81 | |||||||
Cost of revenue | (92) | (80) | (142) | (89) | (97) | (89) | (115) | |
Cost of goods and services sold | (47) | |||||||
Gross profit: | 20 | 6 | 7 | 63 | 36 | 49 | 36 | |
Operating expenses | (115) | (128) | (227) | (262) | (127) | (172) | (166) | |
Operating loss: | (95) | (122) | (220) | (199) | (91) | (123) | (130) | |
Nonoperating income (expense) | (58) | (60) | (48) | 81 | (69) | (35) | (48) | |
Investment income, nonoperating | (47) | (47) | (67) | (62) | (46) | |||
Other nonoperating income (expense) | 0 | (22) | (1) | 127 | (3) | 27 | (2) | |
Interest and debt expense | (58) | (38) | ||||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 58 | 38 | ||||||
Loss from continuing operations before income taxes: | (153) | (182) | (268) | (119) | (160) | (158) | (178) | |
Income tax expense (benefit) | (0) | 2 | (2) | (0) | (0) | (0) | ||
Net loss: | (153) | (182) | (267) | (120) | (160) | (158) | (178) | |
Net income (loss) attributable to noncontrolling interest | 74 | 56 | 33 | (33) | 38 | 32 | 31 | |
Net loss available to common stockholders, diluted: | (78) | (126) | (233) | (153) | (123) | (125) | (147) |
Comprehensive Income ($ in thousands)
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (153) | (182) | (267) | (120) | (160) | (158) | (178) | |
Comprehensive loss: | (153) | (182) | (267) | (120) | (160) | (158) | (178) | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 74 | 56 | (33) | 33 | (38) | (32) | (31) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (18) | (45) | (4) | (118) | 257 | 99 | 26 | |
Comprehensive income (loss), net of tax, attributable to parent: | (97) | (171) | (304) | (206) | 60 | (92) | (184) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.